Kyowa Kirin Invests $530M in First North American Biologics Manufacturing Facility

1. Investment Amount: Kyowa Kirin is investing $530 million in its first biologics manufacturing facility in North America.
2. Location: The facility will be located in Sanford, North Carolina.
3. Job Creation: The project is expected to create over 100 jobs with an average salary of $91,000.
4. Economic Impact: The facility is projected to boost the local economy by $1.05 billion.
5. Board Approval: The investment has received board approval, allowing the company to move forward with the project.
6. Facility Purpose: The facility will accelerate the development and production of biologics for Kyowa Kirin.